In silico drug discovery made easy

We use Big Data and Artificial Intelligence to
accelerate your novel Drug Development through:

SaaS Platform

Our very easy to use SaaS platform provides a versatile set of applications to facilitate target identification and elucidate the mechanisms of action (MoA).

Consultancy Services

We offer broad range of tailor-made and client oriented computational drug discovery services to assist you along the drug design and development pipeline.

From in silico Drug Design to computational prediction of ADME and pharmacokinetics.

Elucidate the Mode of Action (MoA) of specific molecules and rationalize their off-target effects.

In silico screening of libraries, hit & lead expansion and drug repurposing.


Identify and characterize binding sites using Artificial Intelligence approaches.


Oriol Segarra, CEO of Uriach, new member of the Board

Mind the Byte is delighted to announce the appointment Oriol Segarra, CEO of the pharmaceutical company Uriach, as a new member of the board of directors. With his more than 20 years of business experience in global pharmaceutical companies, he is an...

New version of our SaaS platform released

We are happy to announce that this week Mind the Byte has successfully released a new version of the SaaS platform for computational drug design. This new release consists on new versions of our ligand-based softwares, both 2D (Cabrakan, Chaac and Kizin) and 3D...

Drop us a Line